Ontology highlight
ABSTRACT: Background
Neoadjuvant chemotherapy (NAC) induces a pathological complete response (pCR) in ~ 30% of patients with breast cancer. However, aberrant DNA methylation alterations are frequent events during breast cancer progression and acquisition of chemoresistance. We aimed to characterize the inter- and intra-tumor methylation heterogeneity (MH) in breast cancer following NAC.Methods
DNA methylation profiles of spatially separated regions of breast tumors before and after NAC treatment were investigated using high-density methylation microarray. Methylation levels of genes of interest were further examined using multiplexed MethyLight droplet digital PCR (ddPCR).Results
We have discovered different levels of intra-tumor MH in breast cancer patients. Moreover, NAC dr
SUBMITTER: Luo Y
PROVIDER: S-EPMC6367786 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature